Prostate Cancer - Results from #200

T2 mapping for the characterization of prostate lesions. April 4, 2022

Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy by Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer. April 4, 2022

Impact of obesity on perioperative, functional and oncological outcomes after robotic-assisted radical prostatectomy in a high-volume center. April 4, 2022

Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated With Docetaxel Chemotherapy. April 4, 2022

Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator. April 4, 2022

Mount Sinai Health System Launches First-Ever Mobile Prostate Cancer Screening Unit in New York City April 1, 2022

Real-World Effectiveness of Sipuleucel-T on Overall Survival in Men with Advanced Prostate Cancer Treated with Androgen Receptor-Targeting Agents. April 1, 2022

Gating has a negligible impact on dose delivered in MRI-guided online adaptive radiotherapy of prostate cancer. April 1, 2022

Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials. April 1, 2022

Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients. April 1, 2022

Rectal Radiation Dose and Clinical Outcomes in Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy With and Without Hydrogel. April 1, 2022

Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies. March 31, 2022

Grade Migration of Prostate Cancer in the United States during the last decade. March 31, 2022

Comparative performance of fully-automated and semi-automated artificial intelligence methods for the detection of clinically significant prostate cancer on MRI: a systematic review. March 31, 2022

Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer. March 31, 2022

Variation across operating sites in urinary and sexual outcomes after radical prostatectomy in localized and locally advanced prostate cancer. March 31, 2022

Impact of positive surgical margin length and Gleason grade at the margin on oncologic outcomes in patients with nonorgan-confined prostate cancer. March 30, 2022

Absolute PSA after 6 Months of Androgen Deprivation Therapy is a Predictor of Overall and Cancer Specific Mortality in Men with Hormone-Sensitive Prostate Cancer. March 30, 2022

Association of prostate zonal volume with location and aggressiveness of clinically significant prostate cancer: A multiparametric MRI study according to PI-RADS version 2.1. March 30, 2022

Androgen-deprivation therapy and cognitive decline in the NEON-PC prospective study during the COVID-19 pandemic. March 30, 2022

Page 11 of 1224

email news signup